1. Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, et al. Resveratrol: A double-edged sword in health benefits. Biomolecules. 2018;8(4):178.
Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC5040057/3. Mendoza N, Pérez L, Simoncini T. Management of endocrine disease: Benefits of myo-inositol in the treatment of polycystic ovary syndrome. Eur J Endocrinol. 2021;185(4):R55–67.
Available from:
https://pubmed.ncbi.nlm.nih.gov/34638926/4. Vitale SG, Rossetti P, Corrado F, D’Anna R. Metformin and oral contraceptive pills in polycystic ovary syndrome. Arch Gynecol Obstet. 2022;306(5):1359–69.
Available from:
https://pubmed.ncbi.nlm.nih.gov/36272917/5. Zeng Y, Wu Y, Liao X, Song Y, Wang S, Wu J, et al. Gut microbiota modulation in polycystic ovary syndrome: Role of probiotics and prebiotics. Front Endocrinol (Lausanne). 2022;13:829636.
Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8896029/7. Nestler JE, Jakubowicz DJ. Inositol treatment of polycystic ovary syndrome improves ovulatory function. Curr Opin Endocrinol Diabetes Obes. 2021;28(4):297–301.
Available from:
https://pubmed.ncbi.nlm.nih.gov/33991859/9. Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler JE. Myo-inositol effects in women with PCOS: A meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647–58.
Available from:
https://pubmed.ncbi.nlm.nih.gov/27717596/11. Facchinetti F, Unfer V, Dewailly D, Diamanti-Kandarakis E, Baillargeon JP, Nestler J. Inositols in polycystic ovary syndrome: An overview on the advances. Trends Endocrinol Metab. 2015;26(10):509–17.
Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC5655679/12. Regidor PA, Schindler AE. Myo-inositol as a safe and alternative approach in the treatment of infertile PCOS women: A German experience. Gynecol Endocrinol. 2017;33(6):498–500.
Available from:
https://pubmed.ncbi.nlm.nih.gov/29042448/15. Genazzani AD, Prati A, Santagni S, Ricchieri F, Chierchia E, Rattighieri E, et al. Modulatory effects of myo-inositol on hormonal and metabolic parameters in women with PCOS. Gynecol Endocrinol. 2014;30(6):440–3.
Available from:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6823013/16. Formisano C, Cuomo L, de Gregorio V, et al. Role of Myo-Inositol and D-Chiro-Inositol in the Treatment of Polycystic Ovary Syndrome: A Comparative Study. Biomedicines. 2024;12(2):349.
Available from:
https://www.mdpi.com/2227-9059/12/2/34918. Khani B, et al. The effects of vitamin D supplementation on endocrine and metabolic parameters in women with PCOS: A systematic review and meta-analysis. Int J Endocrinol. 2016;2016:8275143.
Available from:
https://pubmed.ncbi.nlm.nih.gov/29946756/